Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 October 2024 | Story André Damons | Photo Supplied
Dr Mutshidzi Mulondo
Dr Mutshidzi Mulondo, academic in the Division of Public Health within the Faculty of Health Sciences at UFS.

Dr Mutshidzi Mulondo, an academic in the Division of Public Health within the Faculty of Health Sciences, at the University of the Free State (UFS), has won a prestigious Global Health Award at the margins of the Global Health Summit in London, the UK.

Dr Mulondo, who is a Novartis Reimagining Healthcare Scholar and a Visiting Scholar at the Beaver College of Health Sciences at Appalachian State University, in the US, was a finalist in two categories: ‘Mental Health and Well-being’ and ‘Rising Star’. She won the Zenith Global Health Award under the category ‘Mental Health and Well-being’. The awards ceremony took place on 28 September and saw health professionals and academics gather in Europe for the auspicious occasion.

“This nomination and selection are an honour that bears testament to my dedication and commitment to SDG 3 (Good Health and Well-being). I hope this win serves as inspiration to young people, particularly to young women in academia and in the sciences,” says Dr Mulondo. The awards are an esteemed platform renowned for celebrating global recognition and excellence, fostering collaboration and innovation in the healthcare sector. They further serve as recognition for contributions made through education, research and/or technology and innovation.

Eco-anxiety

Dr Mulondo, who was invited to attend the summit for the first time, joined a panel of speakers on the session theme ‘mental health and climate change’ where she shared insights on eco-anxiety – the intersection of climate change and mental health which was coined by Albrecht as the chronic fear of environmental change.

Research by the McKinsey Health Institute, says Dr Mulondo, a fellow of the UFS Emerging Scholar Accelerator Programme (ESAP) and member of the UNESCO AG for Women in Science, indicates that more than 75% of young people are pessimistic about the future due to climate change. Most young people in the activism frontlines experience activist burn-out from consistent campaigning, while others experience eco-gaslighting from those who feel climate change is a non-issue. These negative emotions are further exacerbated by young people’s exposure to social media of constant images and conversations about environmental degradation due to climate change.

Pact for the future

Dr Mulondo flew to London from New York after participating in the 79th United Nations General Assembly’s Summit of the Future and Science Summit, as well as the New York Climate Week. She further provided insights into the adoption of the Pact for the Future which was adopted during the Summit of the Future. “With only 17% of the Sustainable Development Goals (SDGs) targets on track to be achieved by 2030, 18% stagnant and 17% regressed to pre-2015 when the goals were first adopted (SDG Report 2024), Mental Health still remains among 10 global health issues to track according to the World Health Organisation (WHO),” says Dr Mulondo.

“The Summit of the Future, which is regarded as a once-in-a-generation high-level event,” she continues, “was aimed at establishing a new global consensus to safeguard the present and future generations. Current challenges such as health pandemics, political unrest, and climatic changes were factored into discussions to keep apace with the changing world in the adoption of the Pact for the Future”.

Recommendations and mitigation efforts should focus on encouraging those experiencing eco-anxiety to focus on joining collective action efforts (i.e. campaigns to clean ocean and beach environments (etc,) so that they feel they are doing something towards saving the planet. “This will help alleviate the feelings of ‘hopelessness’ which some experience from not knowing what to do about the environmental degradation. Furthermore, intergenerational collaboration is necessary for young people to voice their concerns and innovative ideas on the issue, while the older generation listens and further shares their lived wisdom. Ultimately, collective support (Ubuntu) is what is needed as part of the mitigation efforts,” concludes Dr Mulondo.

News Archive

#Women'sMonth: Save the children
2017-08-10

Description: Trudi O'Neill Tags: : rotaviruses, young children, Dr Trudi O’Neill, Department of Microbial, Biochemical and Food Biotechnology, vaccine 

Dr Trudi O’Neill, Senior lecturer in the Department of
Microbial, Biochemical and Food Biotechnology.
Photo: Anja Aucamp

Dr Trudi O’Neill, Senior lecturer in the Department of Microbial, Biochemical and Food Biotechnology, is conducting research on rotavirus vaccines.

Dr O’Neill was inspired to conduct research on this issue through her fascination with the virus. “The biology of rotaviruses, especially the genome structure and the virus’ interaction with the host, is fascinating.”

“In fact, it is estimated that, globally, ALL children will be infected with rotavirus before the age of five, irrespective of their socio-economic standing. However, infants and young children in poor countries are more vulnerable due to inadequate healthcare. The WHO estimates that approximately 215 000 deaths occur each year. This roughly equates to eight Airbus A380 planes, the largest commercial carrier with a capacity of approximately 500 seats, filled with only children under the age of five, crashing each week of every year.”

Alternative to expensive medicines 
“Currently, there are two vaccines that have been licensed for global use. However, these vaccines are expensive and poor countries, where the need is the greatest, are struggling to introduce them sustainably. It is therefore appealing to study rotaviruses, as it is scientifically challenging, but could at the same time have an impact on child health,” Dr O’Neill said.

The main focus of Dr O’Neill’s research is to develop a more affordable vaccine that can promote child vaccination in countries/areas that cannot afford the current vaccines.

All about a different approach 

When asked about the most profound finding of her research, Dr O’Neill responded: “It is not so much a finding, but rather the approach. My rotavirus research group is making use of yeast as vehicle to produce a sub-unit vaccine. These microbes are attractive, as they are relatively easy to manipulate and cheap to cultivate. Downstream production costs can therefore be reduced. The system we use was developed by my colleagues, Profs Koos Albertyn and Martie Smit, and allows for the potential use of any yeast. This enables us to screen a vast number of yeasts in order to identify the best yeast producer.”

Vaccination recently acquired a bad name in the media for its adverse side effects. As researcher, Dr O’Neill has this to say: “Vaccines save lives. By vaccinating your child, you don’t just protect your own child from a potentially deadly infection, but also other children in your community that might be too young to be vaccinated or have pre-existing health problems that prevents vaccination.” 

A future without rotavirus vaccination?

Dr O’Neill believes a future without rotavirus vaccination will be a major step backwards, as the impact of rotavirus vaccines has been profound. “Studies in Mexico and Malawi actually show a reduction in deaths. A colleague in Mozambique has commented on the empty hospital beds that amazed both clinicians and scientists only one year after the introduction of the vaccine in that country. Although many parents, mostly in developed countries, don’t have to fear dehydrating diarrhoea and potential hospitalisation of their babies due to rotavirus infection anymore, such an infection could still be a death sentence in countries that have not been able to introduce the vaccine in their national vaccination programmes,” she said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept